RankingsPricing
  1. JP-listed companies
  2. TAKARA BIO INC.
  3. Financials
  4. Income before tax

TAKARA BIO INC.JP:4974

Market cap
¥94.8B
P/E ratio
-10.5x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 20252,592-23.88%
Mar 31, 20243,405-83.54%
Mar 31, 202320,682-27.33%
Mar 31, 202228,459+101.00%
Mar 31, 202114,159+123.08%
Mar 31, 20206,347+12.04%
Mar 31, 20195,665+46.72%
Mar 31, 20183,861+7.88%
Mar 31, 20173,579+8.42%
Mar 31, 20163,301+19.08%
Mar 31, 20152,772+23.75%
Mar 31, 20142,240+13.99%
Mar 31, 20131,965+7.44%
Mar 31, 20121,829

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)